Browse publications from our 12 P50 Centers in peer-reviewed journals.
Center
Project
Publish Date
Displaying 1 - 10 of 36
Al-Kindi S, Paneni F, Brook RD, Rajagopalan S. Residual environmental risk in patients with cardiovascular disease: an overlooked paradigm. Eur Heart J. 2023 Nov 21;44(44):4612-4614. doi: 10.1093/eurheartj/ehad412. PMID: 37431798; PMCID: PMC10659939.
November 21, 2023
Byrd JB, Bisognano JD, Brook RD. Treating Hypertension in Patients With Orthostatic Hypotension: Benefits vs Harms in the Era of Aggressive Blood Pressure Lowering. JAMA. 2023 Oct 17;330(15):1435-1436. doi: 10.1001/jama.2023.19096. PMID: 37847283.
October 17, 2023
Al-Kindi S, Motairek I, Kreatsoulas C, Wright JT Jr, Dobre M, Rahman M, Rajagopalan S. Historical Neighborhood Redlining and Cardiovascular Risk in Patients With Chronic Kidney Disease. Circulation. 2023 Jul 18;148(3):280-282. doi: 10.1161/CIRCULATIONAHA.123.064215. Epub 2023 Jul 17. PMID: 37459405; PMCID: PMC10361625.
July 17, 2023
Deo SV, Motairek I, Nasir K, Mentias A, Elgudin Y, Virani SS, Rajagopalan S, Al-Kindi S. Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases. JAMA Netw Open. 2023 Jul 3;6(7):e2322727. doi: 10.1001/jamanetworkopen.2023.22727. PMID: 37432687; PMCID: PMC10336624.
July 3, 2023
Motairek I, Dong W, Salerno PR, Janus SE, Ganatra S, Chen Z, Guha A, Makhlouf MH, Hassani NS, Rajagopalan S, Al-Kindi SG. Geographical Patterns and Risk Factor Association of Cardio-Oncology Mortality in the United States. Am J Cardiol. 2023 Aug 15;201:150-157. doi: 10.1016/j.amjcard.2023.06.037. Epub 2023 Jun 27. PMID: 37385168; PMCID: PMC10529631.
June 27, 2023
Al-Kindi S. Leveraging Geospatial Data Science to Uncover Novel Environmental Predictors of Cardiovascular Disease. JACC Adv. 2023 June 7 (4) https://doi.org/10.1016/j.jacadv.2023.100371
June 7, 2023
Motairek I, Makhlouf MHE, Rajagopalan S, Al-Kindi S. The Exposome and Cardiovascular Health. Can J Cardiol. 2023 Sep;39(9):1191-1203. doi: 10.1016/j.cjca.2023.05.020. Epub 2023 Jun 6. PMID: 37290538; PMCID: PMC10526979.
June 6, 2023
Debbs J, Hannawi B, Peterson E, Gui H, Zeld N, Luzum JA, Sabbah HN, Snider J, Pinto YM, Williams LK, Lanfear DE. Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients. J Cardiovasc Transl Res. 2023 Dec;16(6):1343-1348. doi: 10.1007/s12265-023-10397-3. Epub 2023 May 16. PMID: 37191882; PMCID: PMC10651796.
May 16, 2023
Gupta K, Spertus JA, Birmingham M, Gosch KL, Husain M, Kitzman DW, Pitt B, Shah SJ, Januzzi JL, Lingvay I, Butler J, Kosiborod M, Lanfear DE. Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials. Circulation. 2023 Jul 18;148(3):220-228. doi: 10.1161/CIRCULATIONAHA.122.063263. Epub 2023 May 16. PMID: 37191040; PMCID: PMC10523916.
May 16, 2023
Motairek, I, Deo, S, Elgudin, Y. et al. Particulate Matter Air Pollution and Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention. JACC Adv. 2023 May, 2 (3) .
https://doi.org/10.1016/j.jacadv.2023.100285
https://doi.org/10.1016/j.jacadv.2023.100285
May 2, 2023